VIMIZIM (ELOSULFASE ALFA) — FDA Approval BLA125460 (BIOMARIN PHARM)
VIMIZIM (ELOSULFASE ALFA) — FDA Approval BLA125460 (BIOMARIN PHARM) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: VIMIZIM; Active ingredients: ELOSULFASE ALFA; Application number: BLA125460.
| Brand name | VIMIZIM |
|---|---|
| Active ingredients | ELOSULFASE ALFA |
| Application number | BLA125460 |
| Sponsor | BIOMARIN PHARM |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20140214 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →